Laboratorios Farmaceuticos Rovi, S.A.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
E6996D109
SEDOL
B2QS9Z9
CIK
N/A
www.rovi.es
LEI:
©
FIGI: BBG000QP0656
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
GICS: 35202010 · Sector: Consumer Goods - Pharmacy Products and Biotechnology · Sub-Sector: -
NAME
Laboratorios Farmaceuticos Rovi, S.A.
ISIN
ES0157261019
TICKER
ROVI
MIC
XMAD
REUTERS
ROVI.MC
BLOOMBERG
ROVI SM
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
TradingView ActivTrader MT4 MT5
In this section you will find transaction histories for short sales.
ai
NALIZER
Short sellers are obliged to report when building up positions from 0.50% and when reducing positions up to 0.50%. If there are open positions >= 0.50% in the reporting registers, these are shown in the following overview.
One Short sale positions >= 0.50% are currently registered as reportable-relevant
Date Position Holder Position # Action
12.04.2011 JPMorgan Asset Management (UK) Limited 0,50% 3
The overview shows all positions and their last reported status. Please note that when reducing positions, falling below the 0.50% limit means that the mandatory reporting obligations no longer have to be applied. As a rule, it can be assumed that the positions have been completely reduced following a longer period of inactivity. Positions < 0.50% are therefore only of limited significance.
Date Position Holder Position # Action
22.05.2024 Marshall Wace LLP 0,49% 4
30.03.2023 Voleon Capital Management LP 0,47% 4
12.04.2011 JPMorgan Asset Management (UK) Limited 0,50% 3
SHORT SELLING RADAR (“SSR”)
SSR - First TIMER
SSR - DASHBOARD
HEDGE FUND ACTIVITY TRACKER
SSR Weight WATCHER
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.